Clinical Trial Update: Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pembrolizumab for prevention of lung cancer in patients with Stage I-II non-small cell lung cancer or high-risk pulmonary nodules; resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8 | Phase 2 | Status: COMPLETED | Results posted: 2026-04-16